3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
2
Heart Diseases
1
Cardiotoxicity
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
67
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
33
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Immunomodulating Agents
×
Clear all
NCT03530215
2023-04-13
EROCA
Groupe Hospitalier Pitie-Salpetriere
Completed
500,000 enrolled
NCT04696250
2021-01-06
AVATAR
University Hospital, Caen
Unknown
5,000,000 enrolled